Follow the people · Insider

MD

Mittie Doyle

Insider · Chief Medical Officer · AVTX

Mittie Doyle files insider transactions with the SEC as a chief medical officer of Avalo Therapeutics (AVTX). We hold 13 disclosed purchases and sales filed since 1 April 2022, 6 of them in the last 90 days.

  • Files forAVTX
  • Disclosed buys and sells13 in all, 6 in the last 90 days
  • Last disclosure1 September 2026

Positions held

3 posts we hold — a term names its own dates; a run of filings only says when they filed
  • Filed 15 July 202428 August 2026Chief Medical Officer · Avalo Therapeutics (AVTX)63 Form 4 lines · source: SEC Form 4
  • Filed 7 August 202516 June 2026Director · Cullinan Therapeutics (CGEM)2 Form 4 lines · source: SEC Form 4
  • Filed 31 March 20229 August 2023Director · DICE Therapeutics (DICE)2 Form 4 lines · source: SEC Form 4

Everything they disclosed

67 entries, newest first — one per disclosure report, one per Form 4 line

Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.